论文部分内容阅读
目的:研究奥拉西坦治疗脑梗死患者认知障碍的疗效。方法:选取2012年1月到2014年12月三年内在我院接受治疗的脑梗死患者共76例,随机将所有患者分为研究组和对照组,研究组患者加服奥拉西坦。对比两组患者MMSE评分以及疗效。结果:研究组患者在治疗后MMSE评分明显大于对照组;研究组患者在治疗后总有效率和显效率明显高于对照组,以上差异均有统计学意义(P<0.05)。结论:奥拉西坦治疗脑梗死患者认知障碍的疗效明显,值得临床上推广应用。
Objective: To study the curative effect of oxiracetam on cognitive impairment in patients with cerebral infarction. Methods: A total of 76 patients with cerebral infarction treated in our hospital from January 2012 to December 2014 were selected. All patients were randomly divided into the study group and the control group, and the study group plus oxiracetam. MMSE scores and efficacy of two groups were compared. Results: The score of MMSE in study group was significantly higher than that in control group. The total effective rate and markedly effective rate in study group were significantly higher than those in control group (P <0.05). Conclusion: Oxiracetam is effective in treating cognitive impairment in patients with cerebral infarction, which is worthy of clinical application.